Oncology
From preclinical toxicology to clinical safety: The path for...
Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.
Oncology
Advancing the case for cell and gene therapies
After the Advanced Therapies Congress, Europe, pharmaphorum spoke with Resolution Therapeutics' Lara Campana and Vianautis' Dr Sam Barker.
R&D
Sponsored
A data-driven guide to small molecule drug discovery and dev...
A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
R&D
Looking to gene therapy for ocular diseases, with Lance Bald...
Lance Baldo, CEO of Beacon Therapeutics, discusses the transformative power of gene therapy to deliver meaningful outcomes for severe ocular diseases.
Oncology
Radiopharmaceutical development is accelerating. Preclinical...
Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
